Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01150734
What this trial is testing

Neuromodulation in Depressed and Schizophrenic Patients - Changing MEP (Muscle Evoked Potentials) by tDCS (Transcranial Direct Current Stimulation)

Who this might be right for
SchizophreniaDepression
Ludwig-Maximilians - University of Munich 30
Large-scale testing (Phase 3)Looking for participantsNCT06824467
What this trial is testing

Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Merck Sharp & Dohme LLC 770
Large-scale testing (Phase 3)Study completedNCT00973609
What this trial is testing

Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC)

Who this might be right for
Colorectal Neoplasms
AIO-Studien-gGmbH 853
Early research (Phase 1)Study completedNCT04187898
What this trial is testing

Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-Cancer

Who this might be right for
NeutropeniaBreast Cancer
Spectrum Pharmaceuticals, Inc 59
Testing effectiveness (Phase 2)UnknownNCT03356912
What this trial is testing

CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer Progressed During or After a Previous Docetaxel-based Chemotherapy

Who this might be right for
Prostate CancerCastration-resistant Prostate Cancer
Consorzio Oncotech 220
Not applicableStudy completedNCT01185639
What this trial is testing

Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung CarcinomaLiver CancerAdrenal Cancer
Wake Forest University Health Sciences 29
Not applicableLooking for participantsNCT07080944
What this trial is testing

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in IBC

Who this might be right for
Invasive Breast CarcinomaSentinel Lymph Node Biopsy (SLNB)Neoadjuvant Chemotherapy
European Institute of Oncology 75
Early research (Phase 1)Ended earlyNCT01299701
What this trial is testing

A Single Center Study to Characterize the Absorption, Distribution, Metabolism and Excretion (ADME) of ASA404 After a Single Infusion in Patients With Solid Tumors

Who this might be right for
Advanced Solid Tumors
Novartis Pharmaceuticals 7
Testing effectiveness (Phase 2)Study completedNCT01660711
What this trial is testing

A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
Endeavor Health 22
Testing effectiveness (Phase 2)Study completedNCT01931163
What this trial is testing

NECTAR Everolimus Plus Cisplatin in Triple (-) Breast Cancer

Who this might be right for
Breast CancerTriple Negative Breast Cancer
Jenny C. Chang, MD 24
Testing effectiveness (Phase 2)Study completedNCT02756364
What this trial is testing

Sapanisertib in Combination With Fulvestrant in Women With Advanced or Metastatic Breast Cancer After Aromatase Inhibitor Therapy

Who this might be right for
Breast Neoplasms
Calithera Biosciences, Inc 141
Testing effectiveness (Phase 2)Study completedNCT00428714
What this trial is testing

Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and Chemotherapy

Who this might be right for
Prostate Cancer
Eli Lilly and Company 73
Testing effectiveness (Phase 2)UnknownNCT00003634
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
AltaRex 400
Testing effectiveness (Phase 2)Ended earlyNCT00034528
What this trial is testing

Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia

Who this might be right for
HemoglobinopathiesAnemia, Sickle CellHemoglobin SC Disease+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 2
Large-scale testing (Phase 3)Looking for participantsNCT04263298
What this trial is testing

Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Herui Yao 210
Testing effectiveness (Phase 2)UnknownNCT00149136
What this trial is testing

Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly With Imatinib Mesylate (STI571) and Chemotherapy.

Who this might be right for
Acute Lymphocytic Leukemia
Hospices Civils de Lyon 30
Testing effectiveness (Phase 2)Looking for participantsNCT04834544
What this trial is testing

Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care

Who this might be right for
Epithelial Ovarian CarcinomaFallopian Tube CarcinomaPrimary Peritoneal Carcinoma
Peking University Third Hospital 75
Not applicableStudy completedNCT02948764
What this trial is testing

Diagnosis of Pathological Complete Response by Vacuum-assisted Biopsy After Neoadjuvant Chemotherapy in Breast Cancer

Who this might be right for
Breast Neoplasms
Heidelberg University 452
Not applicableUnknownNCT03610854
What this trial is testing

Fitness Trackers During and After Oncological Treatments

Who this might be right for
CancerPhysical ActivityFatigue
University Hospital Tuebingen 50
Large-scale testing (Phase 3)Looking for participantsNCT06498479
What this trial is testing

ARTEMIS-008：HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Hansoh BioMedical R&D Company 460
Next Page